183 related articles for article (PubMed ID: 11316237)
21. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC
Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
[TBL] [Abstract][Full Text] [Related]
22. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy.
Matsuda M; Shikata K; Wada J; Sugimoto H; Shikata Y; Kawasaki T; Makino H
Nephron; 1998 Dec; 80(4):408-13. PubMed ID: 9832639
[TBL] [Abstract][Full Text] [Related]
23. A second serine protease associated with mannan-binding lectin that activates complement.
Thiel S; Vorup-Jensen T; Stover CM; Schwaeble W; Laursen SB; Poulsen K; Willis AC; Eggleton P; Hansen S; Holmskov U; Reid KB; Jensenius JC
Nature; 1997 Apr; 386(6624):506-10. PubMed ID: 9087411
[TBL] [Abstract][Full Text] [Related]
24. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
[TBL] [Abstract][Full Text] [Related]
25. Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2.
Zundel S; Cseh S; Lacroix M; Dahl MR; Matsushita M; Andrieu JP; Schwaeble WJ; Jensenius JC; Fujita T; Arlaud GJ; Thielens NM
J Immunol; 2004 Apr; 172(7):4342-50. PubMed ID: 15034049
[TBL] [Abstract][Full Text] [Related]
26. [Activation mechanism of the complement system].
Matsushita M
Nihon Rinsho; 1999 Feb; 57(2):291-7. PubMed ID: 10077993
[TBL] [Abstract][Full Text] [Related]
27. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments.
Ambrus G; Gál P; Kojima M; Szilágyi K; Balczer J; Antal J; Gráf L; Laich A; Moffatt BE; Schwaeble W; Sim RB; Závodszky P
J Immunol; 2003 Feb; 170(3):1374-82. PubMed ID: 12538697
[TBL] [Abstract][Full Text] [Related]
28. High-dose intravenous immunoglobulin treatment activates complement in vivo.
Mollnes TE; Høgåsen K; De Carolis C; Vaquero E; Nielsen EW; Fontana L; Perricone R
Scand J Immunol; 1998 Sep; 48(3):312-7. PubMed ID: 9743219
[TBL] [Abstract][Full Text] [Related]
29. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway.
Takahashi M; Iwaki D; Kanno K; Ishida Y; Xiong J; Matsushita M; Endo Y; Miura S; Ishii N; Sugamura K; Fujita T
J Immunol; 2008 May; 180(9):6132-8. PubMed ID: 18424734
[TBL] [Abstract][Full Text] [Related]
30. Glomerular deposition of mannose-binding lectin in human glomerulonephritis.
Lhotta K; Würzner R; König P
Nephrol Dial Transplant; 1999 Apr; 14(4):881-6. PubMed ID: 10328463
[TBL] [Abstract][Full Text] [Related]
31. Activation of the lectin complement pathway by H-ficolin (Hakata antigen).
Matsushita M; Kuraya M; Hamasaki N; Tsujimura M; Shiraki H; Fujita T
J Immunol; 2002 Apr; 168(7):3502-6. PubMed ID: 11907111
[TBL] [Abstract][Full Text] [Related]
32. A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway.
Takahashi M; Endo Y; Fujita T; Matsushita M
Int Immunol; 1999 May; 11(5):859-63. PubMed ID: 10330290
[TBL] [Abstract][Full Text] [Related]
33. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL.
Thielens NM; Cseh S; Thiel S; Vorup-Jensen T; Rossi V; Jensenius JC; Arlaud GJ
J Immunol; 2001 Apr; 166(8):5068-77. PubMed ID: 11290788
[TBL] [Abstract][Full Text] [Related]
34. The rat and mouse homologues of MASP-2 and MAp19, components of the lectin activation pathway of complement.
Stover CM; Thiel S; Lynch NJ; Schwaeble WJ
J Immunol; 1999 Dec; 163(12):6848-59. PubMed ID: 10586086
[TBL] [Abstract][Full Text] [Related]
35. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy.
Miyazaki R; Kuroda M; Akiyama T; Otani I; Tofuku Y; Takeda R
Clin Nephrol; 1984 Jun; 21(6):335-40. PubMed ID: 6205804
[TBL] [Abstract][Full Text] [Related]
36. Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway.
Wallis R; Dodds AW; Mitchell DA; Sim RB; Reid KB; Schwaeble WJ
J Biol Chem; 2007 Mar; 282(11):7844-51. PubMed ID: 17204478
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.
Suankratay C; Mold C; Zhang Y; Lint TF; Gewurz H
Clin Exp Immunol; 1999 Sep; 117(3):442-8. PubMed ID: 10469045
[TBL] [Abstract][Full Text] [Related]
38. MASP1 (MBL-associated serine protease 1).
Matsushita M; Endo Y; Fujita T
Immunobiology; 1998 Aug; 199(2):340-7. PubMed ID: 9777417
[TBL] [Abstract][Full Text] [Related]
39. Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway.
Takahashi M; Mori S; Shigeta S; Fujita T
Adv Exp Med Biol; 2007; 598():93-104. PubMed ID: 17892207
[TBL] [Abstract][Full Text] [Related]
40. Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication.
Matsushita M; Endo Y; Fujita T
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):273-83. PubMed ID: 23563865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
